LogicFlo is thrilled to announce a significant milestone in our journey as the pioneering AI Agent workforce for life sciences companies, having successfully raised $2,700,000 in our latest funding round. This transformative investment not only underscores the confidence that investors have in our innovative solutions but also fuels our mission to streamline and revolutionize the workflow within the life sciences sector. At LogicFlo, we merge cutting-edge artificial intelligence with deep industry expertise to create specialized agents that enhance research productivity, support drug discovery processes, and optimize clinical operations. With this funding, we plan to accelerate the development of our proprietary AI technologies, bolstering our operational capabilities and expanding our reach to engage with a broader community of life sciences organizations. Additionally, the infusion of capital will enable us to strategically scale our team—bringing on board more experts in artificial intelligence, data science, and life sciences—ensuring that we continue to set new benchmarks in delivering tailored solutions that address the complexities of modern medical and scientific challenges. This milestone is not only a reflection of our past achievements but also a launchpad for future innovation, empowering our partners to overcome the hurdles of acceleration in research and development. By combining intellectual rigor with agile execution, LogicFlo is positioned to transform how life sciences companies operate, driving efficiency and pushing the boundaries of what is possible in healthcare innovation. We extend our sincere gratitude to our investors and partners for their unwavering support and look forward to leveraging this capital to drive growth and create lasting impact in the field of life sciences.












